Retrospective analysis of capecitabine and oxaliplatin (XELOX) plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer

XELOX plus bevacizumab is an effective treatment strategy and has a manageable tolerability profile when administered to Japanese patients with metastatic colorectal cancer (mCRC). In this study, we retrospectively reviewed cases in which XELOX plus bevacizumab were administered in order to evaluate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: UCHIMA, YASUTAKE, NISHII, TAKAFUMI, ISEKI, YASUHITO, ISHII, MARIKO, HIRAMATSU, SOICHIRO, IWAUCHI, TAKEHIKO, MORIMOTO, JUNYA, KOSAKA, KINSHI, TEI, SEIKA, TAKEUCHI, KAZUHIRO
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2014
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3915698/
https://ncbi.nlm.nih.gov/pubmed/24649322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2013.205
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados